Sun Pharmaceutical Industries Ltd (SUN.NS)
21 Aug 2018
** Shares of India's largest drugmaker rise as much as 2.1 pct to 614.4 rupees, their highest since May 24, 2017
To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_08162018.pdf If you would like to receive this newsletter via email, please register at: https://forms.thomsonreuters.com/india-morning/ FACTORS TO WATCH 11:30 am: Banking Secretary Rajiv Kumar at launch of Canara Bank’s digital branch in New Delhi. LIVECHAT - BONDS UPDATE Reuters interest rate reporter Dhara Ranasinghe delves into gove
India's largest drugmaker Sun Pharmaceutical Industries Ltd posted a first-quarter profit on Tuesday, beating street estimates, helped by stronger sales in the United States.
* Stock top gainer on NSE index (Adds details on U.S. and India sales, share movement)
** Shares of India's largest drug firm Sun Pharmaceutical Industries Ltd rise as much as 7.9 pct to 608.40 rupees on their best day in over 9 weeks
Aug 14 India's largest drugmaker Sun Pharmaceutical Industries Ltd posted a first-quarter profit on Tuesday, beating street estimates.
** April-June quarter should be weak for Cadila Healthcare Ltd and Lupin Ltd with sharp declines in U.S. sales q-o-q - Credit Suisse (CS)
** Sun Pharmaceutical Industries, which has lost more than a third of its market capitalisation in the last three years, shows signs of reversal in downtrend
** Shares of Sun Pharmaceutical Industries gain as much as 3.8 pct to 560.95 rupees - highest since March 6
MUMBAI Supply restrictions imposed on India's largest drugmaker Sun Pharmaceutical Industries by U.S. regulators have been lifted, the company said on Tuesday, removing a major drag on its share price.